ページ2 - 最高の免疫学医師 - トップ93名の医師

EDUCATION

• Graduated in General Medicine at Universidad Autónoma de Nayarit in Mexico
•  
• Training in Forensic Medicine at Jalisco Institute of Forensic Sciences in Mexico
•  
• Training in Regenerative Geriatric Medicine at Nordic University
•  
• Master’s Degree in Regenerative Medicine at Universidad Catolica de Murcia in Madrid, Spain
•  
• Training in Regenerative Medicine at Nordic University

EXPERIENCE

• Founder of the biotechnological institute “Bioplenum S.A de C.V”
•  
• Collaborated in clinical protocols in Lyon, France, with Dr. Lourdes Sagnard
•  
• Clinical researcher in many protocols involving mesenchymal stem cells to treat autoimmune and chronic degenerative diseases, including: diabetes, asthma, ischemic events, ALS (Lou Gehrig’s disease), arthritis, kidney failure, lupus, aesthetic facial regeneration, and as an anti-inflammatory and immunomodulatory agent

ACCOLADES

• HemoFenix France representative in Mexico and Latin America
•  
• Kimicor Pharma representative at the Italian laboratory in Mexico
•  
• Krebs International, General Director for the company located in Bulgaria
•  
• General Director for Immunotherapy for México A.C. foundation

ヴィクトール・アレクサンダー・クロール医師は、デュッセルドルフのザンクト・マルティヌス病院において消化器内科および総合内科の各部門を統括し、消化器疾患および代謝疾患の包括的な診療を専門としています。

• 高度な肥満外科手術技術を備える認定肥満治療センターのセンター長
• 消化管疾患に対する内視鏡的処置の専門家
• 代謝疾患および心血管系疾患の治療を専門とする
• 最新の診断技術を活用した精密な治療計画の立案

Education & Expertise

• 1998 to 2004 – Istanbul University, Istanbul Faculty of Medicine
• 2005 to 2009 – Düzce University, Internal Medicine Specialization
• 2009 to 2010 – Beytüşşebap State Hospital, Compulsory Internal Medicine Service
• 2010 to 2013 – Bülent Ecevit University, Medical Oncology Specialization
• 2013 to 2015 – Recep Tayyip Erdoğan University, Medical Oncology Compulsory Service
• 2015 to Present – Associate Professor, Recep Tayyip Erdoğan University
• 2015 to 2021 – Lecturer, Medical Oncology, Sakarya University Faculty of Medicine
• 2020 to Present – Professor, Sakarya University Faculty of Medicine
• 2020 to Present – Ph.D. Student, Inorganic Chemistry, Sakarya University

Experience

• 2008 – Cleveland Clinic, Rheumatology & Gastroenterology Rotation
• 2016 to 2017 – Northeastern University, The Center for Pharmaceutical Biotechnology and Nanomedicine, Boston, U.S.

Professional Memberships

• TTOD (Turkish Society of Medical Oncology)
• ASCO (American Society of Clinical Oncology)
• ESMO (European Society for Medical Oncology)

Assoc. Prof. Dr. Özlem Köroğlu is a specialist in Physical Medicine and Rehabilitation at Memorial Ankara Hospital (2024–present). She previously served as a faculty member at Gaziler Physical Therapy and Rehabilitation Training and Research Hospital (2016–2024). She was Chief of the Physical Medicine and Rehabilitation Clinic at Elazığ Military Hospital (2011–2015). She earned her MD in 2003 from the GATA Faculty of Medicine. She completed her PM&R residency in 2011.

Her credentials include Ministry of Health–approved certified prolotherapy training. She has taught Prolotherapy and PRP (2022) and Knee Prolotherapy and Campinject (2019). She also taught GETAT and Dextrose Prolotherapy (2018) and ISPRM Ultrasound (2009). She has additional training in musculoskeletal ultrasound, neural therapy, lumbar injections and manipulation, and botulinum toxin treatment for the spastic hand. She attended the Euro‑Mediterranean PRM School in Italy (2010). She is a member of the Turkish Society of PM&R, the Turkish Society for Research and Fight Against Rheumatism, the Association of PM&R Specialists of Türkiye, the Spinal Cord Diseases Association, and the Ankara Medical Chamber.

Education and Expertise

• ISTANBUL UNIVERSITY FACULTY OF MEDICINE
• EGE UNIVERSITY FACULTY OF MEDICINE FACULTY OF MEDICINE

Diseases

• Sexually transmitted diseases
• Fungal Infections
• HIV/AIDS
• Bone and Joint Infections
• Complicated Skin Infections
• Respiratory tract infections
• Tuberculosis
• Urinary Tract Infections
• Viral Hepatitis
• Soft Tissue Infections

Experience

• 2011-2017: Research Assistant – Ege University Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology
• 2017-2021: Specialist Doctor – Ministry of Health, State Hospital
• 2021-2022: Specialist Doctor – Acıbadem M. Ali Aydınlar University Faculty of Medicine
• 2022-Present: Assistant Professor – Izmir University of Economics, Faculty of Medicine

Professional Memberships

• European Society for Clinical Microbiology and Infectious Diseases (ESCMID)
• Turkish Infectious Diseases and Clinical Microbiology Specialists Association (EKMUD)
• Turkish Clinical Microbiology and Infectious Diseases Association (KLİMİK)

Education

GATA Haydarpaşa Training and Research Hospital Istanbul, Turkey

Residency program Sep 2011

Infectious Diseases and Clinical Microbiology Department fellowship program.

Gülhane Military Medical Academy Ankara, Turkey

Bachelor of Science: Medical School Aug 2003

Kuleli Military High School Istanbul, Turkey

High School Diploma Jul 1997

Experience

Health Sciences University Istanbul, Turkey

Associated Professor of Infectious Diseases Aug 2021 - Current

Associated Professor

Sisli Hamidiye Etfal Training and Research Hospital Istanbul, Turkey

Infectious Diseases Physician July 2020–August 2021

Infectious Diseases Physician

Yale School of Medicine Infectious Diseases Department New Haven, CT, USA

Associate Research Scientist June 2019- June2020

Research to improve vaccine against Tick Borne Diseases (Lyme Diseases, Babesiosis etc.)

Yale School of Medicine Infectious Diseases Department New Haven, CT, USA

Visiting Research Scientist Jul 2018 - June2019

Research to improve vaccine against Tick Borne Diseases (Lyme Diseases, Babesiosis etc.)

Turkish Ministry of Health Ankara, Turkey

Head of Health Tourism unit Feb 2017 - June 2018

Improving the health tourism policy of Turkey.

Sisli Hamidiye Etfal Training and Research Hospital Istanbul, Turkey

Infectious Diseases Physician Aug 2016 - June 2018

Infectious Diseases Physician

Tatvan Military Hospital Bitlis , Turkey

Infectious Diseases Physician Jul 2013 - Aug 2016

Infectious Diseases physician

Girne Military Hospital Turkish Republic of Northern Cyprus

Infectious Diseases Physician Oct 2011 - Jun 2013

Infectious diseases physician

GATA Training and Research Hospital Istanbul, Turkey

Residency period Jul 2006 - Sep 2011

4 th. Mechanized Infantry Brigade Command Edirne, Kesan, Turkey

Medical Doctor, May 2004 - Jun 2006

Maintaining the basic health services of the military unit.

Diseases

• Lung Cancer
• Skin Cancers
• Gastrointestinal Cancers
• Genitourinary Cancers
• Gynecological Cancers
• Colon Cancer
• Breast Cancer
• Rare Cancers

Treatment Methods

• Individual Treatments (Comprehensive Genomic Profiling)
• Targeted Therapies
• Immunotherapy
• Cancer Vaccines
• Chemotherapy
• Clinical Research/Experimental Medical Research

Experience

• 2017- 2024: Katip Çelebi University Faculty of Medicine Atatürk Education and Research Hospital Medical Oncology Clinic Associate Professor / Lecturer
• 2022 December – 2023 March: Academic visitor Moffitt Cancer Center Cutaenous Oncology Clinic Tampa, Florida USA
• 2013- 2017: Katip Çelebi University Faculty of Medicine Atatürk Training and Research Hospital – Medical Oncology Clinic Specialist Physician
• 2012-2013: Izmir Education and Research Hospital, Medical Oncology Specialist Physician
• 2012-2012: Mersin State Hospital, Medical Oncology Specialist Physician
• 2010-2012: Dokuz Eylül University Faculty of Medicine, Department of Medical Oncology, Sub-branch Research Assistant
• June-August 2008, December 2008 – February 2009: Memorial Sloan Kettering Cancer Center Observership programme
• 2007-2009: Kartal Education and Research Hospital, Medical Oncology Sub-branch Research Assistant
• 2006-2007: Siirt State Hospital, Internal Medicine, Specialist Physician
• 2005-2006: Çukurova University Faculty of Medicine, Medical Oncology Sub-branch Research Assistant
• 2004-2005: SSK Siirt Hospital, Internal Medicine Specialist Physician
• 2003-2004: SSK Mardin Hospital, Internal Medicine Specialist Physician
• 1998-2003: SSK Izmir Training and Research Hospital, 3rd Internal Medicine Clinic, Research Assistant
• 1998-1998: SSK Izmir Training and Research Hospital Infectious Diseases Research Assistant
• 1997-1998: Izmir Ataturk Training and Research Hospital, Anesthesiology and Reanimation Clinic, Research Assistant
• 1995-1997: Şırnak Cizre Central Health Center
• 1994-1995: Şırnak İdil Oyalı Village Health Center

Professional Memberships

• Turkish Society of Medical Oncology 2008 
• (2018-2021 Term Board Member)
• Izmir Oncology Group, Board Member (2014 -…)
• Geriatric Oncology Association, Board Member (2015-…)
• Mediterranean Oncology Association Board Member (2020 -…)
• Turkish Biochemistry Association, Member, 2016
• European Society of Medical Oncology, Member, 2012
• American Society of Clinical Oncology, Member, 2008

医師は30年以上の経験を持つ免疫学者であり、免疫学の最先端分野であるウイルス療法を専門としています。 <\/p>

リガ医科大学を卒業し、内科でのインターンシップを修了しました。 <\/p>

現在、Pauls Stradins Clinical University Hospitalの臨床免疫学センターの責任者を務めています。<\/p>

Prof. Avichai Shimoni, MD, is Director of Bone Marrow Transplantation at Sheba Medical Center. He is a hemato-oncologist with over 30 years of experience in bone marrow transplantation, cellular therapies, and advanced blood cancer care.

He leads a high-volume program for complex, high-risk blood cancers. He performs allogeneic and autologous transplants. He also provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma. He completed a bone marrow transplantation fellowship at MD Anderson Cancer Center.

He is Chairman of Hematology at Tel Aviv University and a Professor of Hematology. He has authored more than 250 scientific papers. His research focuses on CAR T-cell therapy and stem cell transplantation. He is often listed among Israel's Best Doctors (Forbes 2025 and 2026).

Dr. Hila Magen, MD, leads the Multiple Myeloma and Amyloidosis Unit at Sheba Medical Center. She is a hemato-oncologist with over 35 years of experience. She is a leading Israeli expert in multiple myeloma and plasma cell disorders.

She runs a program that provides personalized care and early access to clinical trials. This includes CAR-T therapy for high-risk and relapsed or refractory myeloma and amyloidosis. Dr. Magen is a principal investigator in point-of-care CAR-T studies. She brings new immunotherapies into routine care.

Training: Fellowships in Multiple Myeloma (UAMS) and Lymphocytic Leukemia (MD Anderson). Academic: Instructor, Tel Aviv University. Research: Author of 100+ publications, contributor to landmark myeloma studies, and reviewer for international journals.

Professor Pnina Langevich is a rheumatologist and immunologist with over 40 years of experience. She leads the National Center for Rheumatology and Autoimmune Diseases at Sheba Medical Center. Forbes Israel has repeatedly named her among the country’s top doctors.

She is an expert in rheumatoid arthritis, osteoarthritis, joint diseases, systemic lupus erythematosus, scleroderma, and complex autoimmune disorders. She treats severe, treatment‑resistant cases using advanced diagnostics and personalized therapy.

She trained in rheumatology and internal medicine at Sheba. She combines patient care with research on new therapies. She served for 12 years as Vice President of the World Association of Rheumatologists. She is Editor‑in‑Chief of Lupus and a member of the Israeli Medical Association and the International Association of Rheumatologists.

Dr. Alireza Soltanzadeh, born in Iran in 1969, is an esteemed anesthesiology and reanimation specialist with over 25 years of experience in critical care, cardiac anesthesia, and algology. After graduating from Urmia University of Medical Sciences in 1995, he quickly specialized in anesthesiology and critical care, beginning his practice abroad in 1998. Furthering his expertise, he completed a fellowship in cardiac anesthesia at Istanbul’s Çapa Medical Faculty and the Siyami Ersek Cardiovascular Center in 2006 and trained in pain management (algology) in 2013. His extensive knowledge in these fields makes him a vital asset to the medical community.

Dr. Soltanzadeh has held pivotal roles throughout his career, including a five-year tenure as Chief Physician at a state hospital in Iran. He has enriched his medical education by completing specialized courses in Germany and continues to be an active member of numerous international anesthesiology and medical societies. Since 2018, he has practiced in Istanbul, contributing his expertise to the private sector and currently serves in the Department of Anesthesiology and Reanimation at Istanbul Okan University Hospital.

Fluent in multiple languages, including English, Farsi, Turkish, Azeri, Kurdish, German, and Arabic, Dr. Soltanzadeh’s professional interests extend to ozone therapy, digital medical device innovation, and enhanced patient safety during anesthesia. His research contributions are recognized internationally, with numerous publications and presentations at renowned anesthesia and pain management congresses worldwide. Dr. Soltanzadeh remains committed to advancing medical standards in his field and continuously expanding his clinical and research expertise.

Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.

He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.

He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.

September 2022 – September 2023: Metabolic Terrain Institute of Health (USA)
2021 – 2023: American Institute of Integrative Oncology
February – May 2019: Swiss Biological Medicine Academy (Switzerland), Education Module 1-6
May 2015: Gerson Institute (USA, California), Gerson Practitioner Training Program, Module 1
2010 – 2013: Riga Gestalt Institute, Psychotherapy (Gestalt Therapy) Studies, Certified Gestalt Practitioner

These experiences reflect a broad and specialized background in integrative oncology, biological medicine, and psychotherapy.

Education and Specialization

HACETTEPE UNIVERSITY FACULTY OF MEDICINE

HACETTEPE UNIVERSITY FACULTY OF MEDICINE INTERNAL MEDICINE DIVISION

ANKARA UNIVERSITY FACULTY OF MEDICINE ALLERGY AND IMMUNOLOGY DIVISION

Experience

2014 - Hacettepe University Hospitals – Internal Medicine Chief Resident

2019 - 2020 Ankara City Hospital – Compulsory Service

2020 - 2022 Şanlıurfa Training and Research Hospital – Compulsory Service

2023 - İzmir University of Economics Medical Point Hospital Allergy and Immunology Clinic

Professional Memberships

Turkish National Allergy and Clinical Immunology Association

İzmir Medical Chamber

Research Publications

Ünsal P, Çerçi P, Açıkgöz ŞA, Keskin G, Ölmez Ü. Serum Levels of Interleukin-36 Receptor Antagonist in Behçet's Patients. Arthritis Rheumatol. 2017. 69(p10).

Gümüşburun R, Görgülü B, Açıkgöz ŞA, Aydın Ö, Çelik GE, Bavbek S. Succesful Rapid Drug Desensitization to Ferric Carboxymaltose in Four Patients. Asthma Allergy Immunology, 2020. 18(01): 47-50.

Ünsal P, Çerçi P, Açıkgöz ŞA, Keskin G, Ölmez Ü. Serum Levels of Interleukin-36 Alpha and Interleukin-36 Receptor Antagonist in Behcet’s Syndrome. Aktuelle Rheumatologie, 2022. 47(03): 233-8.

Oral presentation

Özbek E, Erkoç M, Çolak S, Açıkgöz ŞA, Ölmez Ü, Keskin G. Evaluation of Cardiopulmonary Status in Patients with Common Variable Immunodeficiency. 28th National Allergy and Clinical Immunology Congress, Antalya, 2021 (SS-26)

Açıkgöz ŞA, Erkoç M. Coronavirus Vaccine Attitudes of Hereditary Angioedema Patients in Şanlıurfa Province. 2nd Çukurova Internal Medicine Days, Adana, 2023 (S-369)

Poster presentation

Çolak S, Çerçi P, Açıkgöz ŞA, Yalçıner M, Keskin G, Ölmez Ü. Evaluation of Cases Who Underwent Allergy Testing for Radiocontrast Material. 23rd National Allergy and Clinical Immunology Congress, Bodrum, 2016 (P-080)

Yalçıner M, Çerçi P, Çolak S, Açıkgöz ŞA, Ölmez Ü, Keskin G. Evaluation of Skin Tests Performed with General Anesthetic Agents and Results of Patients Who Underwent Intervention. 23. National Allergy and Clinical Immunology Congress, Bodrum, 2016 (P-081)

Açıkgöz ŞA, Çerçi P, Çolak S, Yalçıner M, Keskin G, Ölmez Ü. How Necessary is Allergy Testing with Local Anesthetic Agents in Patients Describing Drug Allergy? 23. National Allergy and Clinical Immunology Congress, Bodrum, 2016 (P-082)

Çolak S, Çerçi P, Açıkgöz ŞA, Erol C, Keskin G, Ölmez Ü. Hazelnut Allergy with Clinical Symptoms After Organophosphate Exposure at the Age of 70. 23. National Allergy and Clinical Immunology Congress, Bodrum, 2016 (P-123)

Ünsal P, Çerçi P, Açıkgöz ŞA, Keskin G, Ölmez Ü. Serum Levels of Interleukin-36 Receptor Antagonist in Behçet's Patients. ACR/ARHP Annual Meeting, San Diego, CA, 2017 (Abstract Number: 2728)

Şahin D, Kalacı E, Açıkgöz ŞA, Çolak S, Ölmez Ü, Keskin G. Macrophage Activation Syndrome Developing in Follow-up with ADA-2 Deficiency and Response to Anti-TNF Treatment: Case Report. 18th National Rheumatology Congress, Antalya, 2017 (PS-011)

Köroğlu EY, Açıkgöz ŞA, Çerçi P, Ölmez Ü, Keskin G. A Different Case in Internal Medicine Practice: Diagnosis After 25 Years. 19th National Internal Medicine Congress, Antalya, 2017 (PS-275)

Bilgiç E, Açıkgöz ŞA, Keskin G, Ölmez Ü. Chronic Urticaria Associated with Parasitosis: Two Case Series. 24th National Allergy and Clinical Immunology Congress, Antalya, 2017 (P-190)

Çerçi P, Özbek E, Açıkgöz A, Altıner S, Ölmez Ü, Keskin G. The Story of Two Sisters: Could It Be a Genetic Disease Not Yet Identified? 4th Clinical Immunology Congress, Antalya, 2018 (PS-030)

Gümüşburun R, Görgülü B, Açıkgöz ŞA, Aydın Ö, Çelik GE, Bavbek S. Iron Desensitization; With Four Cases. 25th National Allergy and Clinical Immunology Congress, Antalya, 2018 (P-154)

Çolak S, Özbek E, Açıkgöz A, Erkoç M. A Common Variable Immunodeficiency Case Misdiagnosed as Lymphoma. 25th National Allergy and Clinical Immunology Congress, Antalya, 2018 (P-188)

Biography

Our doctor admits patients aged or older than 14.

Medical Education

School of Medicine, 19 Mayıs University

Medical Residency

Infectious Diseases Clinic, Atatürk Teaching and Research Hospital, Izmir

Areas of Interest

Differential diagnosis of fever

Viral hepatitis

Intensive Care Unit Infections

Diabetic Foot

Treatment Methods

• Antibiotherapy
•  
• Antifungal Treatment
•  
• Antiparasitic Treatment
•  
• Antiviral Therapy

Experience

• IZMIR ATATURK TRAINING AND RESEARCH HOSPITAL INFECTIOUS DISEASES CLINIC

Education and Expertise

• MARMARA UNIVERSITY FACULTY OF MEDICINE

Diseases

• Allergic Rhinitis
• Atopic Dermatitis
• Immune System Diseases
• Asthma in Children
• Food Allergies in Children
• Drug Allergy in Children
• Chronic Cough

Experience

• Hacettepe University Faculty of Medicine
• Dokuz Eylul University Faculty of Medicine

Professional Memberships

• Turkish National Association of Allergy and Clinical Immunology
• European Society of Allergy and Clinical Immunology
• Pediatric Allergy and Asthma Academy Association
• Turkish Thoracic Society
• Pediatric Specialist Academy Association